Sign inJoin waitlistJoin the waitlist

Indrani Kar

Program Director, Manager, Formulary and Drug Policy · Case Western Reserve University/University Hospitals Cleveland Medical Center

Credentials: ·

History

Manager, Formulary and Drug Policy · Case Western Reserve University/University Hospitals Cleveland Medical Center
Present

Research

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
Review · CNS Drugs · 2020 · 76 citations
Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic
Review · Multiple Sclerosis and Related Disorders · 2020 · 21 citations
Biosimilar strategic implementation at a large health system
American Journal of Health-System Pharmacy · 2022 · First of 28 authors · 12 citations

Alessandro Serra
2 papers
CC
Claire Chen
2 papers · 2 as a resident
Hesham Abboud
2 papers
Benjamin Tomlinson
1 paper
Brett Glotzbecker
1 paper
Douglas Rhee
1 paper
Jeremy Prunty
1 paper
John Dumot
1 paper
Paula Silverman
1 paper
Prateek Mendiratta
1 paper
Rachael Lerman
1 paper
RS
Robyn Strosaker
1 paper